EXPLORE!

76 lakh compensation in case of blindness in a preterm baby 15; should associations become a party in such cases?

  2945 Views

Dr KK Aggarwal    28 December 2019

Family receives compensation of INR 76 Lakh, after 15 years. The case was treated at Maharaja Agrasen Hospital wherein a pre-term baby turned completely blind. 

A bench of Justices U. U. Lalit and Indu Malhotra held the hospital, its paediatrician and ophthalmologist guilty of medical negligence as they failed to carry out the mandatory retinopathy of prematurity (ROP) check on the pre-term baby, which led to his total blindness. The court also slammed the hospital for not sharing the medical records of the child, born in 2005, with his parents for over two years after discharge to enable them to approach other doctors for treatment.

The baby was brought to the hospital for medical examination from time to time for more than three months, but the doctors never undertook the test.

The bench awarded a compensation of INR 76 lakh out of which INR 60 lakh was allocated for the child’s education, welfare and sustenance. INR 15 lakh was allocated to the mother as his caregiver and INR 1 lakh towards litigation cost. The court upheld the National Consumer Commission’s order that it was a case of medical negligence.

Retinopathy of Prematurity

  1. Retinopathy of prematurity is a developmental vascular proliferative disorder that occurs in the retina of preterm infants with incomplete retinal vascularization.
  2. It is an important cause of severe visual impairment in childhood.
  3. Other ophthalmologic disorders that occur frequently in preterm infants include amblyopia, strabismus, and refractive errors.
  4. Guidelines suggest screening allinfants with birth weight (BW) ≤1500 g or gestational age (GA) ≤30 weeks
  5. One should also screen those with BW between 1500 g and 2000 g or GA >30 weeks whose clinical course places them at increased risk for ROP (as determined by the neonatologist).
  6. Canadian Paediatric Society have suggested screening for infants with birth weight ≤1250 g and infants with GA <31 weeks regardless of BW
  7. Screening for ROP is a labour-intensive process with a relatively low yield; <10 percent of infants who are screened require treatment
  8. The optimal criteria for screening remain uncertain.
  9. Research has focused on developing prediction models to identify high-risk infants with the hope of reducing the number of infants requiring ophthalmologic examinations. However, these methods require additional validation in broad populations before changes to the screening recommendations can be made.
  10. The screening evaluation consists of a comprehensive eye examination performed by an ophthalmologist with expertise in neonatal disorders
  11. The pupil must be dilated in order to visualize the vitreous and retina.
  12. The protocol is to use a combination eyedrop (Cyclomydril, which contains weak concentrations of phenylephrineand cyclopentolate) 30 minutes or more before the examination. Both manipulation of the eye and the cycloplegic eyedrops can produce adverse cardiorespiratory and gastrointestinal effects (e.g., bradycardia, arrhythmia, apnoea, desaturation, emesis). Therefore, it is essential to carefully monitor the infant during and after the examination procedure. Topical anaesthetic can be used based on the preference of the examining clinician
  13. The retina is examined by looking through the pupil with an indirect ophthalmoscope with a 20 or 28 diopter condensing lens while the eyelids are retracted with a speculum. ROP is most commonly visualized in the peripheral retina, which often is obscured by the iris. In order to completely view this area, a scleral depressor is used to indent the eye externally.
  14. Alternatively, telemedicine systems can be used to identify infants with potentially severe ROP. 
  15. Start screening examinations at 30 weeks postmenstrual age (PMA) for infants born at 22 to 26 weeks and at 4 weeks of chronologic age for infants born at ≥27 weeks. Treatable ROP rarely occurs before 31 weeks PMA, most initiate screening at 30 weeks PMA to account for the possibility of errors in dating, examination delays due to medical status, and to permit flexibility in scheduling.
  16. Additional examinations are performed at intervals of one to three weeks until the retinal vessels have completely grown out to the ora serrata (periphery of the retina). If ROP develops, the eyes are examined more frequently, depending upon the severity of disease and rate of progression.

The Indian Retinopathy of Prematurity (IROP) Society

Established in July 2016. The menace of retinopathy of prematurity blindness had reached alarming proportions in the nation. The number of pre-terms born have crossed 3.5 million annually.

Improved neonatal survival, over 700 special neonatal care units (SNCUs), a very low prevalence of ROP screening programs and only a handful of ROP specialists are some of the problems.

With over 20,000 ophthalmologist members of the All India Ophthalmological Society, nearly 2000 are Vitreo-Retinal Society of India members. So less than 1% of ophthalmologists in the country are involved directly in ROP care.

Conclusions: India Ophthalmological Society should have been the party in this case or 10% of all 3.5 million cases of premature deliveries will file cases in courts for compensations as 2000 vitreo- retinal specialist cannot take care of this large number.

After ROP it can be a case of missing all congenital heart diseases in the hospital that amounts to 1% of all births. 

 

 Dr KK Aggarwal

Padma Shri Awardee

President Confederation of Medical Associations in Asia and Oceania (CMAAO)

Group Editor-in-Chief IJCP Publications

President Heart Care Foundation of India

Past National President IMA

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.